These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 12472808)

  • 1. Tumor-suppressive effect of connexin 32 in renal cell carcinoma from maintenance hemodialysis patients.
    Yano T; Ito F; Satoh H; Hagiwara K; Nakazawa H; Toma H; Yamasaki H
    Kidney Int; 2003 Jan; 63(1):381. PubMed ID: 12472808
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypermethylation of the CpG island of connexin 32, a candiate tumor suppressor gene in renal cell carcinomas from hemodialysis patients.
    Yano T; Ito F; Kobayashi K; Yonezawa Y; Suzuki K; Asano R; Hagiwara K; Nakazawa H; Toma H; Yamasaki H
    Cancer Lett; 2004 May; 208(2):137-42. PubMed ID: 15142671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic inactivation of connexin 32 in renal cell carcinoma from hemodialytic patients.
    Yano T; Ito F; Yamasaki H; Hagiwara K; Ozasa H; Nakazawa H; Toma H
    Kidney Int; 2004 Apr; 65(4):1519. PubMed ID: 15086497
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of renal cell carcinoma from hemodialysis patients by regulating epigenetic factors.
    Sumiko S; Hiromi H; Hiromi S; Keiko F; Shigeto K; Taiichiro S; Toyohiko A; Kiyokazu H; Hiroshi Y; Tomohiro Y
    Kidney Int; 2005 Jun; 67(6):2506-7. PubMed ID: 15882304
    [No Abstract]   [Full Text] [Related]  

  • 5. Connexin 32 as an anti-invasive and anti-metastatic gene in renal cell carcinoma.
    Yano T; Fujimoto E; Hagiwara H; Sato H; Yamasaki H; Negishi E; Ueno K
    Biol Pharm Bull; 2006 Oct; 29(10):1991-4. PubMed ID: 17015938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Connexin32 as a tumor suppressor gene in a metastatic renal cell carcinoma cell line.
    Fujimoto E; Sato H; Shirai S; Nagashima Y; Fukumoto K; Hagiwara H; Negishi E; Ueno K; Omori Y; Yamasaki H; Hagiwara K; Yano T
    Oncogene; 2005 May; 24(22):3684-90. PubMed ID: 15782139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Connexin32 as a tumor suppressor gene in renal cell carcinoma].
    Fujimoto E; Yano T; Ueno K
    Nihon Yakurigaku Zasshi; 2007 Feb; 129(2):105-9. PubMed ID: 17299236
    [No Abstract]   [Full Text] [Related]  

  • 8. [Tumorigenesis of kidney tubule].
    Ishikawa I
    Nihon Rinsho; 1995 Aug; 53(8):1900-7. PubMed ID: 7563626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytogenetic features of renal carcinoma].
    Pasechnik DG
    Urologiia; 2003; (5):58-62. PubMed ID: 14658276
    [No Abstract]   [Full Text] [Related]  

  • 10. [2 cases of renal cell carcinoma on long-term hemodialysis].
    Takahara M; Hara S; Matsumura T; Murakami S; Asada M; Matsuzaki O
    Hinyokika Kiyo; 1984 Sep; 30(9):1239-44. PubMed ID: 6524565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic basis of renal cell cancer.
    Linehan WM; Gnarra JR; Lerman MI; Latif F; Zbar B
    Important Adv Oncol; 1993; ():47-70. PubMed ID: 8505056
    [No Abstract]   [Full Text] [Related]  

  • 12. [Renal cell cancer: oncogenes and tumor suppressor genes].
    Dietrich PY; Droz JP
    Rev Prat; 1992 May; 42(10):1236-40. PubMed ID: 1609216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Src family inhibitor (PP1) potentiates tumor-suppressive effect of connexin 32 gene in renal cancer cells.
    Fujimoto E; Sato H; Nagashima Y; Negishi E; Shirai S; Fukumoto K; Hagiwara H; Hagiwara K; Ueno K; Yano T
    Life Sci; 2005 Apr; 76(23):2711-20. PubMed ID: 15792837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequently deleted loci on chromosome 9 may harbor several tumor suppressor genes in human renal cell carcinoma.
    Grady B; Goharderakhshan R; Chang J; Ribeiro-Filho LA; Perinchery G; Franks J; Presti J; Carroll P; Dahiya R
    J Urol; 2001 Sep; 166(3):1088-92. PubMed ID: 11490304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inherited renal neoplasms.
    Torres VE; Bjornsson J; Zincke H
    J Nephrol; 1998; 11(5):229-38. PubMed ID: 9831235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of papillary renal-cell tumours in end-stage kidneys--is there a molecular genetic explanation?
    Kovacs G
    Nephrol Dial Transplant; 1995; 10(5):593-6. PubMed ID: 7566566
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal oncocytoma with bilateral synchronous renal cell carcinoma in a patient undergoing long-term hemodialysis.
    Hamamoto S; Okamura T; Mizuno K; Kamisawa H; Mogami T; Kohri K
    Int J Urol; 2008 Jan; 15(1):87-9. PubMed ID: 18184181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Renal cell carcinoma in chronic hemodialysis patients].
    Imai K; Sekino H; Terasawa Y; Nakamura K
    Nihon Rinsho; 1992 Jan; 50 Suppl():848-54. PubMed ID: 1578777
    [No Abstract]   [Full Text] [Related]  

  • 19. [Tumor suppressor genes associated with development of human renal cell carcinoma].
    Morita R; Hikiji K; Yamakawa K; Nakamura Y
    Nihon Rinsho; 1992 Dec; 50(12):3100-5. PubMed ID: 1491460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal cell carcinoma: recent progress and future directions.
    Mulders P; Figlin R; deKernion JB; Wiltrout R; Linehan M; Parkinson D; deWolf W; Belldegrun A
    Cancer Res; 1997 Nov; 57(22):5189-95. PubMed ID: 9371523
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.